A review of cognitive impairments in dementia with Lewy bodies relative to Alzheimer's disease and Parkinson's disease with dementia

Cortex

Volumn 43, Issue 5, 2007, Pages 583-600

  Metzler Baddeley, Claudia ^a  

^a St Martin's Hospital   (United Kingdom)

Author keywords

Alzheimer's disease; Attention executive function; Lewy body disease; Memory; Perception

Indexed keywords

ALZHEIMER DISEASE; ANOSMIA; ATTENTION DISTURBANCE; BRAIN FUNCTION; CHOLINERGIC SYSTEM; CLINICAL FEATURE; COGNITIVE DEFECT; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; ELECTROENCEPHALOGRAM; EPISODIC MEMORY; EVOKED AUDITORY RESPONSE; HUMAN; MEMORY DISORDER; MENTAL DETERIORATION; MENTAL PERFORMANCE; NEUROIMAGING; NEUROPATHOLOGY; PARKINSON DISEASE; PERCEPTION DISORDER; PERCEPTIVE DISCRIMINATION; REVIEW; SEMANTIC MEMORY; VISUAL HALLUCINATION; VISUAL IMPAIRMENT; WORKING MEMORY;

EID: 34447300709     PISSN: 00109452     EISSN: 00109452     Source Type: Journal    
DOI: 10.1016/S0010-9452(08)70489-1     Document Type: Review

References (108)

1. AARSLAND D, BALLARD CG and HALLIDAY G. Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity? Journal of Geriatry, Psychiatry, and Neurology, 17: 137-145, 2004.
2. AARSLAND D, LITVAN I, SALMON D, GALASKO D, WENTZEL-LARSEN T and LARSEN JP. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: Comparison with progressive supranuclear palsy and Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 74: 1215-1220, 2003.
3. AGGLETON JP and BROWN MW. Episodic memory, amnesia, and the hippocampal-anterior thalamic axis. Behavioural and Brain Sciences, 22: 425-444, 1999.
4. AGGLETON JP and PEARCE JM. Neural systems underlying episodic memory: Insights from animal research. Philosophical Transaction of the Royal Society London B, 29: 1467-1482, 2001.
5. ALA TA, HUGHES LF, KYROUAC GA, GHOBRIAL MW and ELBLE RJ. Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 70: 483-488, 2001.
6. ALA TA, HUGHES LF, KYROUAC GA, GHOBRIAL MW and ELBLE RJ. The Mini-Mental State exam may help in the differentiation of dementia with Lewy bodies and Alzheimer's disease. International Journal of Geriatric Psychiatry, 17: 503-509 2002.
7. ATKINSON J and BRADDICK OJ. "Where" and "what" in visual search. Perception, 18: 181-189, 1989.
8. ATKINSON RC and SHIFFRIN RM. Human memory: A proposed system and its control processes. In Spence KW and Spence JT (Eds), The Psychology of Learning and Motivation (vol. 2). New York: Academic Press, 1968.
9. BADDELEY AD. Working Memory. Oxford: Oxford Psychology Series (no 11), 1992.
10. BADDELEY AD. Working memory: Looking back and looking forward. Nature Reviews Neuroscience, 4: 829-839, 2003.
11. BADDELEY AD, BADDELEY HA, BUCKS RS and WILCOCK GK. Attentional control in Alzheimer's disease. Brain, 124: 1492-1508, 2001.
12. BADDELEY AD, EMSLIE H and NIMMO-SMITH I. The Doors and People Test. Bury St. Edmunds: Thames Valley Test Company, 1994.
13. BADDELEY AD and HITCH GJ. Working memory. In Bower GA (Ed), Recent Advances in Learning and Motivation (vol. 8). New York: Academic Press, 1974.
14. BALLARD CG. Definition and diagnosis of dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders, 17: 15-24, 2004.
15. BALLARD CG, AARSLAND D, MCKEITH I, O'BRIEN J, GRAY A, CORMACK F, BURN D, CASIDY T, STARFELDT R, LARSEN JP, BROWN R and TOVEE M. Fluctuations in attention. Neurology, 59: 1714-1720, 2002.
16. BALLARD CG, JACOBY R, DEL SER T, KHAN MN, MUNOZ DG, HOMES C, NAGY Z, PERRY EK, JOACHIM C, JAROS E, O'BRIEN JT, PERRY RH and MCKEITH IG. Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia. American Journal of Psychiatry, 161: 843-849, 2004.
17. BALLARD CG, WALKER M. O'BRIAN J, ROWAN E and MCKEITH I. The characterisation and impact of "fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease. International Journal of Geriatric Psychiatry, 16: 494-498, 2001.
18. BALLMAIER M, O'BRIEN JT, BURTON EJ, THOMPSON PM, REX DE, NARR KL, MCKEITH IG, DELUCA H and TOGA AW. Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: Diagnosis and gender effects. Neuroimage, 23: 325-335, 2004.
19. BARBER R. BALLARD C, MCKEITH IG, GHOLKAR A and O'BRIEN JT. MRI volumetric study of dementia with Lewy bodies: A comparison with AD and vascular dementia. Neurology, 54: 1304-13099 2000.
20. BARBER R, GHOLKAR A, SCHELTENS P. BALLARD C, MCKEITH IG and O'BRIEN JT. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology, 52: 1153-1158, 1999.
21. BARBER T, PANIKKAR A and MCKEITH IG. Dementia with Lewy bodies: Diagnosis and management. International Journal of Geriatric Psychiatry, 16: 12-18, 2001.
22. BARNES J, BOUBERT L, HARRIS J, LEE A and DAVID AS. Reality monitoring and visual hallucinations in Parkinson's disease. Neuropsychologia, 41: 565-574, 2003.
23. BOEVE BF, SILBER MH and FERMAN TJ. REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies. Journal of Geriatrics, Psychiatry, and Neurology, 17: 146-157, 2004.
24. BOEVE BF, SILBER MH, FERMAN TJ, KOKMEN E, SMITH GE, IVNICK RJ, PARISI JE, OLSON EJ and PETERSEN RC. REM sleep behaviour disorder and degenerative dementia: An association likely reflecting Lewy body disease. Neurology, 51: 363-370, 1998.
25. BRADSHAW J, SALING M, HAPWOOD M, ANDERSON V and BRODTMAN A. Fluctuation cognition in dementia with Lewy bodies and Alzheimer's disease is qualitatively distinguishable. Journal of Neurology, Neurosurgery, and Psychiatry, 75: 382-387, 2004.
26. BURTON EJ, McKEITH IG, BURN DJ, WILIAMS ED and O'BRIEN JT. Cerebral atrophy in Parkinson's disease with and without dementia: A comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain, 127: 791-800, 2004.
27. CAHN-WEINER DA, WILLIAMS K, GRACE J, TREMONT G, WESTERVELT H and STERN RA. Discrimination of dementia with Lewy bodies from Alzheimer's disease and Parkinson disease using the clock drawing test. Cognitive Behavioural Neurology, 16: 85-92, 2003.
28. CALDERON J, PERRY RJ, ERZINCLIOGLU SW, BERRIOS GE, DENING TR and HODGES JJR. Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 70: 157-164, 2001.
29. CERCY SP and BYLSMA FW. Lewy bodies and progressive dementia: A critical review and meta-analysis. Journal of the International Neuropsychological Society, 3: 179-194, 1997.
30. COLLERTON D, BURN D, MCKEITH I and O'BRIEN J. Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia. Dementia and Geriatric Cognitive Disorders, 16: 229-237, 2001
31. COLLOBY SJ, FENWICK JD, WILLIAMS ED, PALING SM, LOBOTESIS K, BALLARD CG, MCKEITH I and O'BRIEN JT. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. European Journal of Nuclear Medicine and Molecular Imaging, 29: 615-622, 2002.
32. COLOSIMO C, HUGHES AJ, KILFORD L and LEES AJ. Lewy body cortical involvement may not always predict dementia in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 74: 852-856, 2003.
33. CORMACK F, AARSLAND D, BALLARD C and TOVEE MJ. Pentagon drawing and neuropsychological performance in Dementia with Lewy bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia. International Journal of Geriatric Psychiatry, 19: 371-377, 2004a.
34. CORMACK F, GRAY A, BALLARD C and TOVEE MJ. A failure of "pop-out" in visual search tasks in dementia with Lewy bodies as compared to Alzheimer's and Parkinson's disease. International Journal of Geriatric Psychiatry, 19: 763-772, 2004b.
35. COURT JA, BALLARD CG, PIGGOTT MA, JOHNSON M, O'BRIEN JT, HOMES C, CAIRNS N, LANTOS P, PERRY RH, JAROs E and PERRY EK. Visual hallucinations are associated with lower alpha bungarotoxin binding in dementia with Lewy bodies. Pharmacology, Biochemistry, and Behaviour 70: 571-579, 2001.
36. CUMMINGS JL. The Neuropsychiatry of Alzheimer's Disease and Related Dementias. London: Martin Dunitz, 2003.
37. CUMMINGS JL. Reconsidering diagnostic criteria for dementia with Lewy Bodies. Reviews in Neurological Diseases, 1: 31-34, 2004.
38. DALRYMPLE-ALFORD J. Comparative Neuropsychology of Lewy body and Alzheimer's dementia. Journal of Neurology, Neurosurgery, and Psychiatry, 72: 148, 2001.
39. DOUBLEDAY EK, SNOWDEN JS, VARMA AR and NEARY D. Qualitative performance characteristics differentiate dementia with Lewy bodies and Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 72: 602-607, 2002.
40. DUCHAMP-VIRET P, CORONAS V, DELALEU JC, MOYSF E and DUCHAMP A. Dopaminergic modulation of mitra cell activity in the frog olfactory bulb: A combined radioligand binding-electrophysiological study. Neuroscience, 79: 203-216, 1997.
41. FERMAN TJ, BOEVE BF, SMITH GE, SILBER MH, KOKMEN E, PETERSEN RC and IVNIK RJ. REM sleep behaviour disorder and dementia: Cognitive differences when compared with AD. Neurology, 52: 951-957, 1999.
42. FERMAN TJ, BOEVE BF, SMITH GE, SILBER MH, LUCAS JA, GRAFF-RADFORD NR, DICKSON DW, PARISI JE, PETERSEN RC and IVNIK RJ. Dementia with Lewy bodies may present as dementia and REM sleep behaviour disorder without Parkinsonism or hallucinations. Journal of International Neuropsychological Society, 8: 907-914, 2002.
43. FERMAN TJ, SMITH GE, BOEVE BF, IVNIK RJ, PETERSEN RC, KNOPMAN D, GRAFF-RADFORD N, PARISI J and DICKSON DW. DLB fluctuations: Specific features that reliably differentiate DLB from AD and normal aging. Neurology, 62: 181-187, 2004.
44. GILBERT PE, BARR PJ and MURPHY C. Differences in olfactory and visual memory in patients with pathologically confirmed Alzheimer's disease and the Lewy body variant of Alzheimer's disease. Journal of the International Neuropsychological Society, 10: 835-842, 2004.
45. GILMAN S, KOEPPE RA, LITTLE R, AN H, JUNCK L, GIORDANI B, PERSAD C, HEUMANN M and WERNETTE K. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F] fluorodeoxyglucose and neuropsychological testing. Experimental Neurology, 191: 95-103, 2005.
46. HAMILTON JM, SALMON DP, GALASKO D, DELIS DC, HANSEN LA, MASLIAH E, THOMAS RG and THAL LI. A comparison of episodic memory deficits in neuropathologically-confirmed Dementia with Lewy bodies and Alzheimer's disease. Journal of the International Neuropsychological Society, 10: 689-697, 2004.
47. HARDING AJ, BROE GA and HALLIDAY GM. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain, 125: 391-403, 2002.
48. HARRINGTON CR, PERRY RH, PERRY EK, HURT J, MCKEITH IG, ROTH M and WISCHIK CM. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. Dementia, 5: 215-228, 1994.
49. HASHIMOTO M, KITAGAKI H, IMAMURA T, HIRONO N, SHIMOMURA T, KAZUI H, TANNIMUKAI S, HANIHARA T and MORI E. Medial temporal and whole-brain atrophy in dementia with Lewy bodies: volumetric MRI study. Neurology, 51: 357-362, 1998.
50. HIGUCHI M, TASHIRO M, ARAI H, OKAMURA N, HARA S, HIGUCHI S, ITOH M, SHIN RW, TROJANOWSKI JQ and SASAKI H. Glucose hypometabolism and neuropathological correlates in brains of Dementia with Lewy bodies. Experimental Neurology, 162: 247-256, 2000.
51. HOLM AD. Alleviation of multiple abnormalities by galantamine treatment in two patients with dementia with Lewy bodies. American Journal of Alzheimer's Disease and Other Dementias, 19: 215-218, 2004.
52. HORIMOTO Y, MAATSUMOTO N, NAKAZAWA H, YUASA H, MORISHUA M, AKATSU H, IKARI H, YAMAMOTO T and KOSAKA K. Cognitive conditions of pathologically confirmed dementia with Lewy bodies and Parkinson's disease with dementia. Journal of the Neurological Sciences, 216: 105-108, 2003.
53. HUBEL D and WIESEL T. Receptive fields of single neurons in the cat's striate cortex. Journal of Physiology, 148: 574-591, 1959.
54. HUBEL, D and WIESEL T. Receptive fields of optic nerve fibres in the spider monkey. Journal of Physiology, 154: 572-580, 1960.
55. HUISMAN E, UYLINGS HB and HOOGLAND PV. 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease. Movement Disorders, 19: 687-692, 2004.
56. HUMPHREYS GW, FREEMAN TA and MULLER HJ. Lesioning a connectionist model of visual search: selective effects on distractor grouping. Canadian Journal of Psychology, 46: 417-427, 1992.
57. HUMPHREYS GW and RIDDOCH MJ. Object agnosias. Balliere's Clinical Neurology, 2: 339-359, 1993.
58. IMAMURA T, ISHII K, SASAKI M, KITAGAKI H, YAMAJI S, HIRONO N, SHIMOMURA T, HASHIMOTO M, TANIMUKAI S, KAZUI H and MORI E. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neuroscience Letters, 235: 49-52, 1997.
59. ISHII K, IMAMURA T, SASAKI M, YAMAJI S, SAKAMOTO S, KITAGAKI H, HASHIMOTO M, HIRONO N, SHIMOMURA T and MORI E. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology, 51: 125-130, 1998.
60. ISHII K, YAMJI S, KITAGAKI H, IMAMURA T, HIRONO M and MORI E. Regional cerebral blood flow differences between dementia with Lewy bodies and AD. Neurology, 53: 413-416, 1999.
61. KATZENSCHLAGER T and LEES AJ. Olfaction and Parkinson's syndrome: Its role in differential diagnosis. Current Opinion in Neurology, 17: 417-423, 2004.
62. KAUFER DI. Pharmacologic treatment expectations in the management of dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders, 17: 32-39, 2004.
63. KNIGHT RT and STUSS DT. Principles of frontal lobe function. London: Oxford University Press, 2002.
64. KNOPMAN DS, DEKOSKY ST, CUMMINGS JL, CHUI H, COREY-BLOOM J, RELKIN N, SMALL GW, MILLER B and STEVENS JC. Practice parameter: Diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 56: 1143-1153, 2001.
65. LAMBON-RALPH MA, POWELL J, HOWEARD D, WHITWORT AB, GARRARD P and HODGES JR. Semantic memory is impaired in both dementia with Lewy bodies and dementia of Alzheimer's type: A comparative neuropsychological study and literature review. Journal of Neurology, Neurosurgery, and Psychiatry, 70: 149-156, 2001.
66. LAWRENCE AD and SAHAKIAN BJ. The cognitive psychopharmacology in Alzheimer's disease: Focus on cholinergic systems. Neurochemical Research, 23: 787-794, 1998.
67. LEBERT F, PASQUIER F, SOULIEZ L and PETIT H. Tacrine efficacy in Lewy body dementia. International Journal of Geriatric Psychiatry, 13: 516-519, 1998.
68. LEMSTRA AW, EIKELENBOOM P and VAN GOOL WA. The cholinergic deficiency syndrome and its therapeutic implications. Gerontology, 49: 55-60, 2003.
69. LIPPA CF and MCKEIT I. Dementia with Lewy bodies. Neurology, 60: 1571-1572, 2003.
70. MANDLER G. Recognizing: The judgement of previous occurrence. Psychological Review, 87: 252-271, 1980.
71. MCKEITH IG. Dementia with Lewy bodies. British Journal of Psychiatry, 180: 144-147, 2002.
72. MCKEITH IG, BALLARD CG, PERRY RH, INCE PG, O'BRIEN JT, NEILL D, LOWERY K, JAROS E, BARBER R, THOMPSON P, SWANN A, FAIRBAIRN AF and PERRY EK. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology, 14: 1050-1058, 2000a.
73. MCKEITH IG, DEL SER T, SPANO P, EMRE M, WESNES K, ANAND T, CICIN-SAIN A, FERRARA T and SPIEGEL R. Efficacy of rivastigmine in dementia with Lewy bodies: A randomised, double-blind, placebo-controlled international study. Lancet, 16: 2031-2036, 2000b.
74. MCKEITH IG, GALASKO D, KOSAKA K, PERRY EK, DICKSON DW, HANSEN LA, SALMON DP, LOWE J, MIRRA SS, BYRNE EJ, LENNOX G, QUINN NP, EDWARDSON JA, INCE PG, BERGERON C, BURNS A, MILLER BL, LOVESTONE S, COLLERTON D, JANSEN EN, BALLARD C, DE VOS RA, WILCOCK GK, JELLINGER KA and PERRY RH. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology, 47: 1113-1124, 1996.
75. McKEITH IG, MINTZER J, AARSLAND D, BURN D, CHIU H, COHEN-MANSFIELD J, DICKSON D, DUBOIS B, DUDA JE, FELDMAN H, GAUTHIER S, HALLIDAY G, LAWLOR B, LIPPA C, LOPEZ OL, MACHADO J, O'BRIEN J, PLAYFER J and REID W. International Psychogeriatric Association Expert Meeting on DLB. Dementia with Lewy bodies. Lancet Neurology, 3: 19-28, 2004a.
76. McKFITH IG and MOSIMANN UP. Dementia with Lewy bodies and Parkinson's disease. Parkinsonism and Related Disorders, 10: 15-18, 2004.
77. MCKEITH IG, WESNES KA, PERRY E and FERRARA R. Hallucinations predict attentional improvements with rivastigmine in dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders, 18: 94-100, 2004b.
78. MCSHANE RH, NAGY Z, ESIRI MM, KING E, JOACHIM C, SULLIVAN N and SMITH AD. Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology. Journal of Neurology, Neurosurgery, and Psychiatry, 70: 739-743, 2001.
79. MERDES AR, HANSEN LA, JESTE DV, GALASKO D, HOFSTETTER CR, Ho GJ, THAL LJ and COREY-BLOOM J. Influence of Alzheimer's pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology, 60: 1586-1590, 2003.
80. MORI E, SHIMOMURA T, FUJIMORI M, HIRONO N, IMAMURA T, HASHIMOTO M, TANIMUKAI S, KAZUI H and HANIHARA T. Visuoperceptual impairment in dementia with Lewy bodies. Archive Neurology, 57: 489-493, 2000.
81. MOSIMANN UP, MATHER G, WESNES KA, O'BRIEN JT, BURN DJ and MCKEITH IG. Visual perception in Parkinson disease dementia and dementia with Lewy bodies. Neurology, 14: 2091-2096, 2004.
82. NOE E, MARDER K, BELL KL, JACOBS DM, MANLY JJ and STERN Y. Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia. Moving Disorders, 19: 60-67, 2004.
83. NORMAN DA and SHALLICE T. Attention to action: Willed and automatic control of behaviour. In Davidson RJ, Schwartz GE and Shapiro D (Eds), Consciousness and Self-Regulation. New York: Plenum Press, 1986.
84. PERRIOL MP, DUJARDIN K, DERABURE P, MARCQ A, BOURRIEZ JL, LAUREAU E, PASQUIER F, DEFEBVRE L and DESTEE A. Disturbances of sensory filtering in dementia with Lewy bodies: comparison with Parkinson's disease dementia and Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 76: 106-108, 2005.
85. PERRY EK, HAROUTUNIAN V, DAVIS KL, LEVY R, LANTOS P, EAGGER S, HONAVAR M, DEAN A, GRIFFITHS M, McKEITH IG ET AL. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuroreport, 5: 747-749, 1994.
86. PERRY EK, MARSHALL E, KERWIN J, SMITH CJ, JABEEN S, CHENG AV and PERRY RH. Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia. Journal of Neurochemistry, 55: 1454-1456, 1990.
87. PERRY RJ and HODGES JR. Attention and executive deficits in Alzheimer's disease: A critical review. Brain, 122: 383-404, 1999.
88. PETIT D, GAGNON JF, FANTINI ML, FERINI-STRAMBI L and MONTPLAISIR J. Sleep and quantitative EEG in neurodegenerative disorders. Journal of Psychosomatic Research, 56: 487-496, 2004.
89. POSNER MI and PETERSEN SE. The attention system of the human brain. Annual Review in Neuroscience, 13: 25-42, 1990.
90. RAMPELLO L, CERASA S, ALVANO A, BUTTA V, RAFFAELE R, VECCHIO I, CAVALARO T, CIMINO E, INCOGNITO T and NICOLETTI F. Dementia with Lewy bodies: A review. Archives of Gerontology and Geriatrics, 39: 1-14, 2004.
91. SALMON DP, GALASKO D, HANSEN LA, MASLIA E, BUTTERS N, THAL L and KATZMAN R. Neuropsychological deficits associated with diffuse Lewy body disease. Brain and Cognition, 31: 148-165, 1996.
92. SAMUEL W, ALFORD M, HOFSTETTER CR and HANSEN L. Dementia with Lewy bodies versus pure Alzheimer's disease: Differences in cognition, neuropathology, cholinergic, dysfunction, and synapse density. Journal of Neuropathology and Experimental Neurology, 56: 499-508, 1997.
93. SAMUEL W, CALIGIURI M, GALASKO D, LACRO J, MARINI M, MCCLURE FS, WARREN K and JESTE DV. Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: Preliminary study. International Journal of Geriatric Psychiatry, 15: 794-802, 2000.
94. SHALLICE T. From neuropsychology to mental structure. Cambridge: Cambridge University Press, 1988.
95. SHIMOMURA T, MORI E, YAMASHITA H, IMAMURA T, HIRONO N, HASHIMOTO M, TANIMUKAI S, KAZUI H and HANINARA T. Cognitive loss in dementia with Lewy bodies and Alzheimer disease. Archive Neurology, 55: 1547-1552, 1998.
96. SIMARD M, VAN REEKUM R and COHEN T. A review of the cognitive and behavioural symptoms in dementia with Lewy bodies. Journal of Neuropsychiatry and Clinical Neuroscience, 12: 425-450, 2000.
97. SIMARD M, VAN REEKUM R and MYRAN D. Visuospatial impairment in Dementia with Lewy bodies and Alzheimer's disease: A process analysis approach. International Journal of Geriatric Psychiatry, 18: 387-391, 2003.
98. SIMARD M, VAN REEKUM R, MYRAN D, PANISSET M, COHEN T, FREEDMAN M, BLACK S and SUVAJAC B. Differential memory impairment in dementia with Lewy bodies and Alzheimer's disease. Brain and Cognition, 49: 244-249, 2002.
99. TAM CW, BURON EJ, McKEITH IG, BURN DJ and O'BRIEN JT. Temporal lobe atrophy on MRI in Parkinson disease with dementia: A comparison with Alzheimer disease and dementia with Lewy bodies. Neurology, 64: 861-865, 2005.
100. THOMPSON-SCHILL SL. Neuroimaging studies of semantic memory: Inferring "how" from "where". Neuropsychologia, 41: 280-292, 2003.
101. TSUBOI Y and DICKSON DW. Dementia with Lewy bodies and Parkinson's disease with dementia: Are they different? Parkinsonism and Related Disorders, 11: 47-51, 2005.
102. TULVING E. Elements of Episodic Memory. Oxford: Oxford Science Publications Series (no 2), 1983.
103. UNGERLEIDER LG and MISHKIN M. Two cortical systems. In Ingle DJ, Goodale MA and Mansfield RJ (Eds), Analysis of Visual Behavior. Cambridge, MA: MIT Press, 1982.
104. WALKER MP, AYRE GA, CUMMINGs JL, WESNES K, McKEITH IG, O'BRIEN JT and BALLARD CG. The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. British Journal of Psychiatry, 177: 252-256, 2000a.
105. WALKER MP, AYRE GA, CUMMINGS JL, WESNES K, McKEITH IG, O'BRIEN JT and BALLARD CG. Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. Neurology, 54: 1616-1624, 2000b.
106. WALKER Z, COSTA DC, JANSSEN AG, WALKER RW, LIVINGSTONE G and KATONA CL. Dementia with Lewy bodies: A study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon emission tomography. European Journal of Nuclear Medicine, 24: 609-614, 1997.
107. WESTERVELT HJ, STERN RA and TREMONT G. Odor identification deficits in diffuse Lewy body disease. Cognitive Behavioral Neurology, 16: 93-99, 2003.
108. WILCOCK GK and SCOTT MI. Tacrine for senile dementia of Alzheimer's or Lewy body type. Lancet, 344: 544, 1994.